Processing

Please wait...

Settings

Settings

Goto Application

1. WO2021067243 - TREHALOSE FORMULATIONS AND USES THEREOF

Publication Number WO/2021/067243
Publication Date 08.04.2021
International Application No. PCT/US2020/053226
International Filing Date 29.09.2020
IPC
A61P 3/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
3Drugs for disorders of the metabolism
A61K 9/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
A61K 31/075 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
075Ethers or acetals
Applicants
  • SEELOS THERAPEUTICS, INC. [US]/[US]
Inventors
  • MEHRA, Raj
  • WASIEWSKI, Warren
  • KRISHNA, Gopal
Agents
  • BATES, Caleb A.
  • FOLLETT, Angela D.
Priority Data
62/908,78401.10.2019US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) TREHALOSE FORMULATIONS AND USES THEREOF
(FR) FORMULATIONS DE TRÉHALOSE ET LEURS UTILISATIONS
Abstract
(EN)
The present disclosure relates to methods of treating or alleviating one or more symptoms of mucopolysaccharidoses in a subject, via administering a trehalose formulation to the subject.
(FR)
La présente invention concerne des procédés de traitement ou d'atténuation d'un ou de plusieurs symptômes de mucopolysaccharidoses chez un sujet par l'administration d'une formulation de tréhalose.
Latest bibliographic data on file with the International Bureau